Siddhartha Kar
banner
siddharthakar.bsky.social
Siddhartha Kar
@siddharthakar.bsky.social
associate professor, University of Cambridge | research group leader, Early Cancer Institute | genetic epidemiology for cancer prevention and early detection
Reposted by Siddhartha Kar
Our paper using exome case-control data to identify HELB as a susceptibility gene (i.e. loss-of-function variants risk associated) for non-mucinous, non-high-grade serous epithelial ovarian cancer out now in EJHG. Team too many to name.
rdcu.be/d9BL9
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer
European Journal of Human Genetics - Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer
rdcu.be
February 12, 2025 at 4:54 PM
Reposted by Siddhartha Kar
Join Gib Hemani and my MR programme at the IEU,
Details in the links below
We are seeking a talented researcher to join our programme on Mendelian randomisation as either research fellow or senior research associate, depending on past experience. Apply by 5 Feb www.bristol.ac.uk/jobs/find/de... @mendelrandom.bsky.social
Details | Working at Bristol | University of Bristol
www.bristol.ac.uk
January 8, 2025 at 12:21 PM
Reposted by Siddhartha Kar
Looking for a #phd in #biostatistics, #machinelearning or #ai? MRC biostatistics unit in Cambridge, one of the largest groups in Europe, has funded positions. Topics include casual mechanisms, trials, study design, population health, precision medicine, machine learning, AI. Come and join us!
PhD Programme | MRC Biostatistics Unit
We actively support equality, diversity and inclusion and encourage applications from all sections of society. We are committed to widening participation in postgraduate education. The MRC Biostatisti...
www.mrc-bsu.cam.ac.uk
January 3, 2025 at 6:53 PM
Reposted by Siddhartha Kar
Latest study on evaluating the multifactorial BOADICEA model, implemented in CanRisk (www.canrisk.org), for predicting 10-year breast cancer risks in the prospective #UKBiobank cohort, from our @antonis02.bsky.social group, published in JNCI
doi.org/10.1093/jnci...
@crukcamcentre.bsky.social
Evaluating the performance of the BOADICEA model in predicting 10-year breast cancer risks in UK Biobank
AbstractBackground. The BOADICEA model predicts breast cancer risk using cancer family history, epidemiological and genetic data. We evaluated its validity
doi.org
December 16, 2024 at 11:30 AM